Nova Leap Health Corp (NLH)
Executive Summary
Nova Leap Health is a consolidator of an extremely fragmented space of home care and home health care agencies. Nova Leap buys them at ~5x EBITDA and subsequently improves EBITDA margin. As the company scales its operations, the operating leverage would lead to margin expansion. The stock price has an upside of ~100% in 1 year.
Opportunity
1) Small Cap (50m)
2) Sell side has not discovered it yet
3) Flying under the radar
Nova presently has a 2.1m cash pile and a long term debt of 2.7m, debt was 5.3M in August with a 2.7M cash pile
Business Overview
NLH is home care and home health care services company operating in Vermont, New Hampshire, Massachusetts, Rhode Island, Oklahoma, Ohio, and Nova Scotia. NLH all entered into all these markets (except for Ohio) through M&A transactions.
Home care covers such activities as:
Dementia care
Personal grooming like bathing or getting dressed
Moving around: getting in and out of the bed/shower
Medication reminders
Errands like grocery shopping and picking up prescriptions
Light housekeeping
Meal preparation
Home healthcare covers such activities as:
Skilled nursing
At-home physical therapy
Pain Management
Caring for wounds
Prescription management
Customer Value Proposition
Home care and home healthcare enables senior citizens to stay in their homes even after they cannot live completely on their own. Homecare crates a buffer from when a senior citizen needs to move to a nursing facility
COVID-19 Tailwind
Senior citizens living at nursing facilities suffered greatly from COVID-19. There were instances where a big part of a nursing home’s population got infected by COVID-19. Second, many senior citizens got locked down at nursing facilities and were not able to see family members for very extended periods of time for safety reasons. Needless to say, that was a real hardship.
Thus, I expect that both senior citizens and their families (e.g., children) would be trying to avoid or at least delay moving to a nursing facility as long as possible which would provide strong tailwinds for home care industry and Nova Leap.
M&A Strategy
1. M&A Criteria
Nova Leap has the following acquisition criteria:
1) U.S. and Canada geographic focus
2) Positive EBITDA with strong reputation/brand
3) Normally 5+ year history
4) Opportunities for operational synergies
5)
1M-15M of Revenues
Nova Leap is going after targets that are too small for private equity players and as a result faces limited competition. The space is very fragmented, and Nova Leap has many potential acquisition targets in front of it.
M&A Playbook and Integration
Nova Leap buys home care businesses that are primarily private pay. After that Nova Leap makes incremental changes at the acquired operations.
First, Nova Leap implements price increases where it is appropriate.
Second, Nova Leap reducea overtime because overtime destroys gross profit margin.
Third, Nova Leap consolidates the back-office functions such as accounting. For example, instead of an accountant looking after one agency, such account working at Nova Leap HQ would be looking after 3 or 4 home care agencies.
Fourth, better scheduling using scheduling software.
Operating Philosophy
CEO Chris Dobbin runs Nova Leap in a very decentralized fashion. Most locations’ leaders have lots of autonomy. HQ are responsible for setting up standards and back office / accounting. Chris Dobbin spends his time heavily on M&A and overseeing the agencies’ leaders.
Unit Economics
The key operating drivers are the number of client service hours and revenue per hour. Revenue per hour has been quite stable and is ~$25.
Cost per hour has also been stable: ~$16.50 - $17.00.
Thus, the profit per hour is ~$8.50 to $9.
Four-Wall Economics and Four-Wall EBITDA
“Four-wall EBITDA” is of course a misnomer because there are no tangible walls to speak of, but the concept still applies. I want to analyze profitability of field operations first and then overlay HQ expenses on top of that. The key issue that Nova Leap is facing today is its small size of field operations vs. HQ. However, with a few more acquisitions and de minimis growth in HQ expenses (see more on this below), the operating leverage would kick in and lead to a disproportionate increase in EBITDA.
In 2019 segment EBITDA margin (e.g., before HQ costs) was 11.88%. However, in 1Q 2020 and 2Q 2020 it was 10.91% and 10.39% respectively due to the COVID-19 impact.
Revenue run-rate (ex-COVID-19) is ~5M per quarter or ~20M per year. With ~12% segment EBITDA margin, NLH should be able to generate ~~2.4M of segment EBITDA. With the EV of ~19M, the EV/Segment EBITDA is ~7.85x.
HQ Operations
The HQ team based in Halifax is small and includes CEO, CFO, controller, and business development person. This is purely corporate function.
The HQ also has 5 accountants. However, they work with field agencies.
Nova Leap wants to do 4 to 6 M&A transactions a year (there was zero during COVID-19 pandemic so 2020 number would probably be lower than this target). Doing these M&A transactions will not require hiring any more HQ personnel. However, Nova Leap would probably need to hire an accountant for every 3-4 acquisitions (maybe 5).
HQ expenses are ~280K - 300K per quarter when there are no M&A transactions. Let’s call it 1.2M per year.
Scaling
What the numbers above is mean is that Nova Leap needs to get another1M of EBITDA to show the strength of its operating model. That would probably require 5M of capital. I expect that it will be done with a very small dilution to existing shareholders.
Valuation and Upside Potential
As I alluded above, current headline multiple of EBITDA is not particularly attractive. However, with getting more scale and proving the model, I would not be surprised if Nova Leap trades at 12x – 14x EBIDA in 1 year could generate a 100% upside
Risks
M&A Integration
M&A integration risks are inherent for any roll up / consolidation strategy and NLH is not exception.
2. Leverage
NLH has ~2.0M of debt which is a lot given its EBITDA today. If NLH does not grow its EBITDA, its leverage can become an issue.
Catalysts
1. Continuous M&A
2. Operating leverage showing up as the company continues to scale its operations.
Nova Leap Health is a consolidator of an extremely fragmented space of home care and home health care agencies. Nova Leap buys them at ~5x EBITDA and subsequently improves EBITDA margin. As the company scales its operations, the operating leverage would lead to margin expansion. The stock price has an upside of ~100% in 1 year.
Opportunity
1) Small Cap (50m)
2) Sell side has not discovered it yet
3) Flying under the radar
Nova presently has a 2.1m cash pile and a long term debt of 2.7m, debt was 5.3M in August with a 2.7M cash pile
Business Overview
NLH is home care and home health care services company operating in Vermont, New Hampshire, Massachusetts, Rhode Island, Oklahoma, Ohio, and Nova Scotia. NLH all entered into all these markets (except for Ohio) through M&A transactions.
Home care covers such activities as:
Dementia care
Personal grooming like bathing or getting dressed
Moving around: getting in and out of the bed/shower
Medication reminders
Errands like grocery shopping and picking up prescriptions
Light housekeeping
Meal preparation
Home healthcare covers such activities as:
Skilled nursing
At-home physical therapy
Pain Management
Caring for wounds
Prescription management
Customer Value Proposition
Home care and home healthcare enables senior citizens to stay in their homes even after they cannot live completely on their own. Homecare crates a buffer from when a senior citizen needs to move to a nursing facility
COVID-19 Tailwind
Senior citizens living at nursing facilities suffered greatly from COVID-19. There were instances where a big part of a nursing home’s population got infected by COVID-19. Second, many senior citizens got locked down at nursing facilities and were not able to see family members for very extended periods of time for safety reasons. Needless to say, that was a real hardship.
Thus, I expect that both senior citizens and their families (e.g., children) would be trying to avoid or at least delay moving to a nursing facility as long as possible which would provide strong tailwinds for home care industry and Nova Leap.
M&A Strategy
1. M&A Criteria
Nova Leap has the following acquisition criteria:
1) U.S. and Canada geographic focus
2) Positive EBITDA with strong reputation/brand
3) Normally 5+ year history
4) Opportunities for operational synergies
5)
1M-15M of RevenuesNova Leap is going after targets that are too small for private equity players and as a result faces limited competition. The space is very fragmented, and Nova Leap has many potential acquisition targets in front of it.
M&A Playbook and Integration
Nova Leap buys home care businesses that are primarily private pay. After that Nova Leap makes incremental changes at the acquired operations.
First, Nova Leap implements price increases where it is appropriate.
Second, Nova Leap reducea overtime because overtime destroys gross profit margin.
Third, Nova Leap consolidates the back-office functions such as accounting. For example, instead of an accountant looking after one agency, such account working at Nova Leap HQ would be looking after 3 or 4 home care agencies.
Fourth, better scheduling using scheduling software.
Operating Philosophy
CEO Chris Dobbin runs Nova Leap in a very decentralized fashion. Most locations’ leaders have lots of autonomy. HQ are responsible for setting up standards and back office / accounting. Chris Dobbin spends his time heavily on M&A and overseeing the agencies’ leaders.
Unit Economics
The key operating drivers are the number of client service hours and revenue per hour. Revenue per hour has been quite stable and is ~$25.
Cost per hour has also been stable: ~$16.50 - $17.00.
Thus, the profit per hour is ~$8.50 to $9.
Four-Wall Economics and Four-Wall EBITDA
“Four-wall EBITDA” is of course a misnomer because there are no tangible walls to speak of, but the concept still applies. I want to analyze profitability of field operations first and then overlay HQ expenses on top of that. The key issue that Nova Leap is facing today is its small size of field operations vs. HQ. However, with a few more acquisitions and de minimis growth in HQ expenses (see more on this below), the operating leverage would kick in and lead to a disproportionate increase in EBITDA.
In 2019 segment EBITDA margin (e.g., before HQ costs) was 11.88%. However, in 1Q 2020 and 2Q 2020 it was 10.91% and 10.39% respectively due to the COVID-19 impact.
Revenue run-rate (ex-COVID-19) is ~5M per quarter or ~20M per year. With ~12% segment EBITDA margin, NLH should be able to generate ~~2.4M of segment EBITDA. With the EV of ~19M, the EV/Segment EBITDA is ~7.85x.
HQ Operations
The HQ team based in Halifax is small and includes CEO, CFO, controller, and business development person. This is purely corporate function.
The HQ also has 5 accountants. However, they work with field agencies.
Nova Leap wants to do 4 to 6 M&A transactions a year (there was zero during COVID-19 pandemic so 2020 number would probably be lower than this target). Doing these M&A transactions will not require hiring any more HQ personnel. However, Nova Leap would probably need to hire an accountant for every 3-4 acquisitions (maybe 5).
HQ expenses are ~280K - 300K per quarter when there are no M&A transactions. Let’s call it 1.2M per year.
Scaling
What the numbers above is mean is that Nova Leap needs to get another
1M of EBITDA to show the strength of its operating model. That would probably require 5M of capital. I expect that it will be done with a very small dilution to existing shareholders. Valuation and Upside Potential
As I alluded above, current headline multiple of EBITDA is not particularly attractive. However, with getting more scale and proving the model, I would not be surprised if Nova Leap trades at 12x – 14x EBIDA in 1 year could generate a 100% upside
Risks
M&A Integration
M&A integration risks are inherent for any roll up / consolidation strategy and NLH is not exception.
2. Leverage
NLH has ~2.0M of debt which is a lot given its EBITDA today. If NLH does not grow its EBITDA, its leverage can become an issue.
Catalysts
1. Continuous M&A
2. Operating leverage showing up as the company continues to scale its operations.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。